Sit Investment Associates Inc. Sells 7,700 Shares of Cabot Corporation $CBT

Sit Investment Associates Inc. decreased its holdings in Cabot Corporation (NYSE:CBT) by 43.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,000 shares of the specialty chemicals company’s stock after selling 7,700 shares during the quarter. Sit Investment Associates Inc.’s holdings in Cabot were worth $663,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in CBT. NewEdge Advisors LLC increased its position in Cabot by 2,559.5% during the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock valued at $82,000 after purchasing an additional 947 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after purchasing an additional 108,645 shares during the period. Empowered Funds LLC boosted its stake in shares of Cabot by 102.6% during the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock valued at $2,341,000 after purchasing an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Cabot by 3.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock valued at $10,145,000 after purchasing an additional 4,048 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its position in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the period. Institutional investors own 93.18% of the company’s stock.

Analyst Ratings Changes

CBT has been the subject of a number of research reports. UBS Group increased their price target on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Friday, May 8th. JPMorgan Chase & Co. lifted their price objective on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Wednesday, May 13th. Mizuho upped their target price on Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Truist Financial began coverage on Cabot in a research report on Monday, June 8th. They issued a “buy” rating and a $98.00 target price for the company. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $83.80.

Cabot Stock Down 0.4%

NYSE:CBT opened at $91.43 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. The firm’s 50-day moving average price is $81.52 and its 200-day moving average price is $74.78. The company has a market capitalization of $4.72 billion, a PE ratio of 17.28, a P/E/G ratio of 12.07 and a beta of 0.82. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $91.80.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.30 million. During the same quarter in the previous year, the business earned $1.90 earnings per share. The firm’s quarterly revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities analysts predict that Cabot Corporation will post 6.34 EPS for the current fiscal year.

Cabot Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 29th were given a $0.4725 dividend. The ex-dividend date of this dividend was Friday, May 29th. This represents a $1.89 annualized dividend and a dividend yield of 2.1%. This is a boost from Cabot’s previous quarterly dividend of $0.45. Cabot’s payout ratio is presently 35.73%.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.